Rhythm Pharmaceuticals Inc. – RYTM: SEC Investigation Update
Warning. A formal and undisclosed SEC investigation into identified patients, anticipated number of patients, and population data just ended in December 2020. In our opinion, this most certainly should have been disclosed to investors. We obtained some of the related documents. Full details in today’s report. Removed from Watch List of Companies with Undisclosed SEC Investigations.
Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC. Our work is heavily reliant on company disclosures and our expertise in using the Freedom of Information Act.
To access the full SEC Investigation Update report we published on this company (only visible when logged-in).